Should I Buy AORT Stock in 2026?

Data-driven analysis and honest assessment for Artivion Inc

Analysis Updated:
CAUTIONSeveral concerns warrant careful consideration

Current Price: $36.39P/E: 173.3

Decision Score

4.1/10

Weak

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)2/10

Very high P/E of 173.3 suggests overvaluation

Growth (20%)5/10

Slow growth of 0%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)4/10

Low FCF yield of 2.2%

Insider Activity (10%)5/10

No recent insider activity

Key Investment Metrics

Current Price

$36.39

P/E Ratio

173.29

Revenue Growth

0.2%

Profit Margin

0.0%

Market Cap

$1.7B

Dividend Yield

None

How AORT Compares to Competitors

Understanding how AORT stacks up against peers helps inform your investment decision.

How AORT Compares to Peers

Upcoming Events for AORT

+5 Reasons TO Buy AORT

1. High gross margins of 64%

moderate

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

-5 Reasons NOT to Buy AORT

1. Expensive valuation at 173x earnings

high risk

P/E of 173 is significantly above averages. High expectations leave little room for disappointment.

2. Thin profit margins of 0.0%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

3. High PEG ratio of 181.5

high risk

PEG above 2 suggests expensive relative to growth rate.

4. Small-cap volatility risk

medium risk

Market cap under $2B means higher volatility and lower liquidity.

5. Minimal revenue growth

low risk

Growth of 0.2% barely keeps pace with inflation.

Who Should Buy AORT?

Investment Profile

Risk Level

Very High

Recommended Holding Period

3-5 years

Best For:

  • Momentum Traders

    High-growth profile attracts momentum

Not Suitable For:

  • Growth Investors

    Limited 0% growth may disappoint

  • Value Investors

    Premium P/E of 173 doesn't fit value criteria

  • Income-Focused Retirees

    No dividend paid

  • Risk-Averse Investors

    Very High risk may cause uncomfortable volatility

Consider These Alternatives

If you're interested in AORT, compare these Health Care peers:

Pro tip: Compare AORT directly with competitors using our comparison tool to see which stock better fits your criteria.

Get the Full Picture

Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for AORT

Frequently Asked Questions

What is AORT stock price today?

AORT (Artivion Inc) stock is trading at $36.39 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AORT stock going up or down today?

AORT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AORT stock now?

The decision to buy AORT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AORT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AORT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AORT stock overvalued or undervalued?

AORT currently trades at a P/E ratio of 173.29, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if AORT is fairly priced.

What is AORT's P/E ratio?

AORT has a price-to-earnings (P/E) ratio of 173.29, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AORT's market cap?

AORT (Artivion Inc) has a market capitalization of $1.74 billion, making it a small-cap stock.

What is AORT's price to book ratio?

AORT trades at a price-to-book (P/B) ratio of 3.89, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Similar Investment Decisions

Explore investment analyses for stocks similar to Artivion Inc

Explore Categories

Disclaimer

This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.